Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Arcus Biosciences, Inc. (RCUS)
Last arcus biosciences, inc. earnings: 3/5 04:10 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Company Participants Holli Kolkey - Vice President of Corporate Communications Terry Rosen - Co-Founder, Chairman & CEO Richard Markus - Chief Medical Officer Jennifer Jarrett - Chief Operating Officer Juan Jaen - Co- Founder & President Robert Goeltz - Principal Financial Officer & CFO Conference Call Participants Salim Syed - Mizuho Securities USA LLC, Research Division Daniel Bronder Yigal Nochomovitz - Citigroup Inc., Research Division Jonathan Miller - Evercore ISI Institutional Equities, Research Division Emily Bodnar - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Hello, everyone, and thank you for joining the Arcus Biosciences Full Year and Fourth Quarter 2025 Earnings and Financial Results Call. My name is Claire and I'll be coordinating your call today. [Operator Instructions] I will now hand over to Holli Kolkey from Arcus Biosciences to begin. Please go ahead. Holli Kolkey Vice President of Corporate Communications
Show less
Read more
Impact Snapshot
Event Time:
RCUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCUS alerts
High impacting Arcus Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RCUS
News
- Arcus Biosciences to Participate in Two Upcoming Investor ConferencesBusiness Wire
- Arcus (RCUS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update [Yahoo! Finance]Yahoo! Finance
- Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline UpdateBusiness Wire
- Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney CancerBusiness Wire
RCUS
Earnings
- 2/25/26 - Beat
RCUS
Sec Filings
- 2/25/26 - Form S-3ASR
- 2/25/26 - Form S-8
- 2/25/26 - Form 10-K
- RCUS's page on the SEC website